Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Quest Diagnostics Incorporated DGX

Healthcare  —  Diagnostics & Research
236.32 (0.27) (0.11%) as of 25 Sep
Market cap
$26.2B
P/E
24.8×
S&P 500 Member Dividend Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Quest Diagnostics Incorporated (DGX) EV/EBITDA

As of 25 September 2026, Quest Diagnostics Incorporated (DGX) trades at a EV/EBITDA of 14.1×. Over the past ten years it has ranged from 6.4× (June 2021) to 14.7× (September 2026); the current reading is higher than 99% of that period. That is below the Diagnostics & Research industry median of 25.2× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 11.5× (5.40%)
FY2024 12.2× 4.71%
FY2023 11.6× (0.12%)
FY2022 11.7× 31.24%
FY2021 8.9× 10.00%
FY2020 8.1× (29.60%)
FY2019 11.5× 7.19%
FY2018 10.7× (10.74%)
FY2017 12.0× 12.07%
FY2016 10.7× 32.32%

Quarterly

Period EV/EBITDA Change
Jun 2026 12.9× 5.25%
Mar 2026 12.3× 6.42%
Dec 2025 11.5× (9.32%)
Sep 2025 12.7× 0.73%
42 more quarters

Against its own ten years

Low 6.4× High 14.7×
Ten-year median 11.3×
Current reading's percentile 99

EV/EBITDA against peers

Company EV/EBITDA
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated 14.1×
LH Labcorp Holdings Inc. compare 14.7×
RVTY Revvity Inc. compare 24.5×
MTD Mettler-Toledo International, Inc. compare 24.9×
IDXX IDEXX Laboratories, Inc. compare 25.6×
MEDP Medpace Holdings, Inc. compare 28.0×
ILMN Illumina, Inc. compare 36.0×
WAT Waters Corporation compare 49.8×
Diagnostics & Research industry median 25.2×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on DGX